Carla Boquimpani
0000-0001-7396-2495
Publication & Citation Trends
Publications
77 total
External validation and calibration of the HoLISTIC Consortium's advanced‐stage Hodgkin lymphoma international prognostic index (A‐HIPI) in the Brazilian Hodgkin lymphoma registry
Cited by 2
Semantic Scholar
Real World Evidence From 2 Decades of First-Line TKI Therapy in Chronic Myeloid Leukemia (CML): Insights From ACHO's RENEHOC Registry.
Cited by 2
Semantic Scholar
Asciminib vs bosutinib in chronic-phase chronic myeloid leukemia previously treated with at least two tyrosine kinase inhibitors: longer-term follow-up of ASCEMBL PDF
Cited by 128
OpenAlex
Matching-adjusted indirect comparison of asciminib versus other treatments in chronic-phase chronic myeloid leukemia after failure of two prior tyrosine kinase inhibitors PDF
Cited by 20
OpenAlex
Treatment outcomes in classic Hodgkin lymphoma: 5‐year update from the Brazilian Hodgkin Lymphoma Registry OA
Cited by 5
Semantic Scholar
External Validation of the Advanced-Stage Hodgkin Lymphoma International Prognostic Index (A-HIPI): Strong Calibration in the Brazilian Prospective Hodgkin Lymphoma Registry OA
Cited by 1
Semantic Scholar
TREATMENT PATTERNS AND OUTCOMES FOR HODGKIN'S LYMPHOMA (HL) PATIENTS (PTS) AGED 60 AND OLDER: A REPORT FROM THE BRAZILIAN PROSPECTIVE HODGKIN'S LYMPHOMA REGISTRY OA
Cited by 1
Semantic Scholar
Long-term outcomes with frontline nilotinib versus imatinib in newly diagnosed chronic myeloid leukemia in chronic phase: ENESTnd 10-year analysis PDF
Cited by 340
OpenAlex
Research Topics
Chronic Myeloid Leukemia Treatments
(59)
Chronic Lymphocytic Leukemia Research
(35)
Eosinophilic Disorders and Syndromes
(14)
Acute Lymphoblastic Leukemia research
(13)
Lymphoma Diagnosis and Treatment
(12)
Affiliations
Universidade Federal do Rio de Janeiro
OncoMed (United States)
Hemorio
Sociedade Brasileira de Oncologia Clínica
Hospital de Clínicas